Pacific View Asset Management’s AnaptysBio ANAB Stock Holding History

Pacific View Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,925	Closed	-$214K	–	51
2019 Q1	$214K	Buy	+2,925	New	+$202K	0.22%	52
2018 Q4	–	Sell	-2,470	Closed	-$245K	–	57
2018 Q3	$245K	Buy	+2,470	New	+$205K	0.2%	83
2018 Q2	–	Sell	-1,976	Closed	-$205K	–	97
2018 Q1	$205K	Buy	+1,976	New	+$223K	0.15%	108

Other funds holding ANAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacific View Asset Management's ANAB Position: Q2 2019 in Review

Pacific View Asset Management sold out of AnaptysBio (ANAB) in Q2 2019, closing a stake of 2,925 shares — an estimated $214K sold.

Pacific View Asset Management first reported a position in ANAB in Q1 2018 and held it in 3 quarters. The position peaked at $245K in Q3 2018. 127 funds tracked by Wall St. Rank hold ANAB as of Q2 2019.

Pacific View Asset Management reported no remaining AnaptysBio position as of Q2 2019 after selling out during the quarter.
Pacific View Asset Management sold 2,925 AnaptysBio shares in Q2 2019, an estimated $214K.
Pacific View Asset Management first reported a position in AnaptysBio in Q1 2018 and held it in 3 quarters.
Pacific View Asset Management's AnaptysBio position peaked at $245K in Q3 2018.
127 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2019.

Based on Pacific View Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.